The time of taking drugs after surgery for early stage lung cancer cannot be generalized. Generally, patients with early stage lung cancer such as IIA or above or Ib with high risk factors and the presence of EGFR mutation take two years of targeted drugs for adjuvant therapy.
Lung cancer is a malignant tumor originating from the bronchial mucosal epithelium. It is currently believed that the cause of lung adenocarcinoma is closely related to smoking, ionizing radiation, heredity and other factors. Early stage lung cancer refers to the primary tumor lesion with a diameter of less than 3cm, without regional lymph node metastasis and without distant organ metastasis.
Early-stage lung cancer requires radical surgery according to the condition. After surgery, according to the clinical stage of the tumor, pathology and patient’s status, most of the patients do not need chemotherapy and other special drugs after surgery, while a small number of patients need to be treated with adjuvant chemotherapeutic drugs under the guidance of doctors, but there is no fixed requirement on the time of specific medication.
For early stage postoperative lung cancer patients, it is recommended to follow the doctor’s instructions to go to regular hospitals for regular follow-up and standardized diagnosis and treatment under the guidance of specialists, and if oral medication is needed, it is necessary to refer to the opinion of specialists to discontinue the medication, and don’t discontinue the medication by oneself.